Court win for Unit­ed Ther­a­peu­tics will re­strain loom­ing com­pe­ti­tion for its soon-to-be block­buster

Unit­ed Ther­a­peu­tics claimed vic­to­ry ear­li­er this week in a patent bat­tle against Liq­uidia Tech­nolo­gies, which won ten­ta­tive FDA ap­proval for its tre­pros­tinil in­hala­tion pow­der, Yutrepia …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER